4-(benzyloxy)-3-[(1R)-3-(dipropan-2-ylamino)-1-phenylpropyl]benzoic acid

We are 4-(benzyloxy)-3-[(1R)-3-(dipropan-2-ylamino)-1-phenylpropyl]benzoic acid CAS:754159-68-7 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:4-(benzyloxy)-3-[(1R)-3-(dipropan-2-ylamino)-1-phenylpropyl]benzoic acid
CAS.NO:754159-68-7
Synonyms:4-(benzyloxy)-3-[(1R)-3-(dipropan-2-ylamino)-1-phenylpropyl]benzoic acid
benzoicacid, 3-[(1r)-3-[bis(1-methylethyl)amino]-1-phenylpropyl]-4-(phenylmethoxy)-
3-[(1r)-3-[bis(1-methylethyl)amino]-1-phenylpropyl]-4-(phenylmethoxy)benzoic acid
 
Physical and Chemical Properties:
Molecular Formula C29H35NO3
Molecular Weight 445.59300
 
Specification:
Appearance:White or off white crystalline powder
Assay:≥98.0%
Residue on ignition:≤0.5%
Loss on drying:≤0.5%
Heavy metals:≤20ppm
Any single impurity:≤1.0%
Total impurities:≤2.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Fesoterodine Fumarate(CAS:286930-03-8).

4-(benzyloxy)-3-[(1R)-3-(dipropan-2-ylamino)-1-phenylpropyl]benzoic acid


Related News: The drug substance is an active product that has completed the synthetic route, and the intermediate is a product in one place in the synthetic route.2,4-dihidroxibenzofenona CAS:131-56-6 With the improvement of people’s living standards and the aging degree, the demand for medicines has been increasing for a long time. Therefore, the transfer from finished medicines to bulk medicines has greatly promoted the demand for bulk medicines.2-fenilacetamida CAS:103-81-1 With the improvement of people’s living standards and the aging degree, the demand for medicines has been increasing for a long time. Therefore, the transfer from finished medicines to bulk medicines has greatly promoted the demand for bulk medicines.Ácido 1 – ((4-fluorofenil) carbamoil) ciclopropanocarboxílico CAS:849217-48-7 With the improvement of people’s living standards and the aging degree, the demand for medicines has been increasing for a long time. Therefore, the transfer from finished medicines to bulk medicines has greatly promoted the demand for bulk medicines.According to statistics, in the ten years from 2008 to 2017, a total of 13 “China Class 1” small-molecule chemical drugs were independently researched and developed by domestic enterprises in China and approved by the CFDA; in 2018, there were 10 varieties of domestic Class 1 new drugs. Approved for listing in China.

Related Products
Product Name
2-bromo-4-fluorophenyl chlorothioformate View Details
4-Chloronitrobenzene View Details
L-Ornithine L-Aspartate View Details
4-Methylpiperidine manufacturer 3-Bromo-4-fluorobenzaldehyde manufacturer chloromethyl(trimethyl)silane manufacturer L-Glutamic acid dimethyl ester hydrochloride manufacturer 3-Chloro-5-fluorobenzonitrile manufacturer